Your browser doesn't support javascript.
loading
Heterozygous loss of Dip2B enhances tumor growth and metastasis by altering immune microenvironment.
Adlat, Salah; Hayel, Farooq; Chen, Yang; Sah, Rajiv Kumar; Mar Oo, Zin; Al-Azab, Mahmoud; Zun Zaw Myint, May; Bahadar, Noor; Binta Bah, Fatoumata; Mi, Nasser; Safi, Mohammed; Feng, Xuechao; Zhu, Ping; Zheng, Yaowu.
Afiliação
  • Adlat S; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510100, China; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Hayel F; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Chen Y; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China; School of Life Sciences, Xuzhou Medical University, Jiangsu, Xuzhou 221004, China.
  • Sah RK; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China; School of Medicine, Southern University of Science and Technology, Shenzhen 518005, Guangdong, China.
  • Mar Oo Z; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Al-Azab M; Department of Immunology, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou 510623, China.
  • Zun Zaw Myint M; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Bahadar N; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Binta Bah F; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China.
  • Mi N; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510100, China.
  • Safi M; Department of Oncology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
  • Feng X; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China. Electronic address: fengxc997@nenu.edu.cn.
  • Zhu P; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510100, China. Electronic address: tanganqier@163.com.
  • Zheng Y; Transgenic Research Center, School of Life Sciences, Northeast Normal University, Changchun, Jilin 130024, China; Cardiovascular Research Institute, University of California, San Francisco, CA 94158, United States. Electronic address: zhengyw442@nenu.edu.cn.
Int Immunopharmacol ; 105: 108559, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35091337
ABSTRACT
Cancer is caused by abnormal cell growth and metastasis to other tissues. Development of cancers is complex and underlining mechanisms are mostly unknown. Disco-interacting protein 2 homolog B (DIP2B) is a member of Dip2. There have been reports suggesting that Dip2B may participate in tumor growth and development. However, direct link between DIP2B and cancer development is missing. In this study, Dip2btm1a/+ heterozygous knockout mouse model was used to investigate tumor growth and metastasis. Results show that one allele knockout of Dip2B significantly promoted tumor growth and metastasis, decreased tumor cell apoptosis and reduced immune cell infiltration in tumors, most likely by altering immune system that includes reduction of macrophage and cytotoxic T-cells infiltration into tumor microenvironment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias / Proteínas do Tecido Nervoso Limite: Animals Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Neoplasias / Proteínas do Tecido Nervoso Limite: Animals Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2022 Tipo de documento: Article